Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKP.L Regulatory News (SKP)

  • There is currently no data for SKP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

13 Jan 2010 18:17

RNS Number : 5208F
Skyepharma PLC
13 January 2010
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

SkyePharma Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

Delta adjustment

 X

3. Full name of person(s) subject to the notification obligation:

D.E. Shaw & Co., L.P. D.E. Shaw & Co. (U.K.), Ltd.

4. Full name of shareholder(s) (if different from 3.):

 N/A

5. Date of the transaction and date on which the threshold is crossed or reached:

 January 11, 2010

6. Date on which issuer notified:

 January 13, 2010

7. Threshold(s) that is/are crossed or reached:

 32%

  

8. Notified details:

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

 

 

 

 

 

 

 

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
 
Type of financial instrument
Exercise price
Expiration date
Exercise/ Conversion period
Number of voting rights instrument refers to
% of voting rights
 
Contract for Differences ("CfD") relating to convertible bond due 2024
 
March 4, 2010
 
3,461,725
Nominal
Delta 
 
14.46%
CfD relating to convertible bond due 2025
 
December 3, 2010
 
2,058,916
Nominal
Delta
 
8.60%
CfD relating to convertible bond due 2025
 
June 3, 2010
 
 2,058,916
Nominal
Delta
 
 8.60%

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 

7,579,557

 

31.66%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

 

Each of D.E. Shaw & Co., L.P. ("DESCO LP") and D.E. Shaw & Co. (U.K.), Ltd. ("DESCO UK") is notifying solely in its capacity as a discretionary investment manager. As general partner of DESCO LP, D.E. Shaw & Co., Inc. ("DESCO Inc.") is a parent undertaking of DESCO LP and DESCO UK. By virtue of David E. Shaw's position as president and sole shareholder of DESCO, Inc., which is the general partner of DESCO LP, David E. Shaw is a parent undertaking of DESCO LP and DESCO UK.

Proxy Voting:

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

13. Additional information:

 

14. Contact name:

Stephen Back (Compliance Department)

15. Contact telephone number:

+1 212-478-0000 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLDXLFFBFFLBBD
Date   Source Headline
21st May 20094:59 pmRNSConversion of ?50,000 6% 2024 Bonds
15th May 200911:20 amRNSAGM Results
15th May 20097:03 amRNSBoard Appointment
15th May 20097:00 amRNSInterim Management Statement
11th May 20097:00 amRNSConversion of Bonds
1st May 20094:50 pmRNSShare Purchase Plan
24th Apr 200910:00 amRNSAnnual Information Update
21st Apr 200911:53 amRNSDirector/PDMR Shareholding
14th Apr 20097:00 amRNSAnnual Financial Report
1st Apr 20095:41 pmRNSShare Purchase Plan
31st Mar 200910:47 amRNSTotal Voting Rights
31st Mar 20097:02 amRNSRe Agreement
26th Mar 20097:00 amRNSFinal Results
25th Mar 20093:09 pmRNSConversion of Bonds
23rd Mar 20097:00 amRNSRegulatory Application
20th Mar 200912:47 pmRNSConversion of Bonds
17th Mar 20099:51 amRNSHolding(s) in Company
11th Mar 20093:56 pmRNSDirector Declaration
6th Mar 200912:43 pmRNSConversion of Bonds
5th Mar 20091:40 pmRNSConsultation Process
4th Mar 20094:41 pmRNSSecond Price Monitoring Extn
4th Mar 20094:36 pmRNSPrice Monitoring Extension
4th Mar 20099:55 amRNSShare Purchase Plan
26th Feb 20094:36 pmRNSPrice Monitoring Extension
10th Feb 20094:35 pmRNSPrice Monitoring Extension
10th Feb 20092:19 pmRNSTotal Voting Rights
4th Feb 20095:56 pmRNSShare Purchase Plan
2nd Feb 200911:36 amRNSHolding(s) in Company
21st Jan 20097:00 amRNSResearch Update
7th Jan 20092:50 pmRNSDirector/PDMR Shareholding
7th Jan 20097:00 amRNSEuropean Product Approval
19th Dec 20087:00 amRNSUpdate on Formoterol Certihaler
11th Dec 200810:00 amRNSResearch Update
25th Nov 200811:36 amRNSPiper Jaffray 2008 Health Care Conference
19th Nov 20084:36 pmRNSPrice Monitoring Extension
17th Nov 20086:04 pmRNSShare Purchase Plan
14th Nov 20084:44 pmRNSDirector/PDMR Shareholding
27th Oct 20087:00 amRNSInterim Management Statement
23rd Oct 20087:00 amRNSResearch Update
13th Oct 20084:36 pmRNSPrice Monitoring Extension
9th Oct 20084:36 pmRNSPrice Monitoring Extension
3rd Oct 200811:00 amRNSStatement re Convertible Bonds
2nd Oct 20088:21 amRNSHolding(s) in Company
1st Oct 20085:51 pmRNSHolding(s) in Company
1st Oct 20082:51 pmRNSHolding(s) in Company
30th Sep 20083:50 pmRNSHolding(s) in Company
29th Sep 20083:02 pmRNSDirector/PDMR Shareholding
29th Sep 200810:08 amRNSHolding(s) in Company
26th Sep 200810:12 amRNSVoting Rights and Capital
26th Sep 200810:05 amRNSDirector Declaration - Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.